User contributions
From WikiPathways
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
- 14:26, 17 September 2019 Homo sapiens:Amino acid metabolism pathway excerpt: histidine catabolism extension (ChEBI identifier normalization)
- 14:26, 17 September 2019 Homo sapiens:DNA replication (ChEBI identifier normalization)
- 14:26, 17 September 2019 Homo sapiens:22q11.2 copy number variation syndrome (ChEBI identifier normalization)
- 14:26, 17 September 2019 Homo sapiens:Aerobic glycolysis - augmented (ChEBI identifier normalization)
- 14:26, 17 September 2019 Homo sapiens:Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway (ChEBI identifier normalization)
- 14:26, 17 September 2019 Homo sapiens:Glycosylation and related congenital defects (ChEBI identifier normalization)
- 14:26, 17 September 2019 Homo sapiens:Molybdenum cofactor (Moco) biosynthesis (ChEBI identifier normalization)
- 14:25, 17 September 2019 Homo sapiens:Relationship between inflammation, COX-2 and EGFR (ChEBI identifier normalization)
- 14:25, 17 September 2019 Homo sapiens:Vitamin D in inflammatory diseases (ChEBI identifier normalization)
- 14:25, 17 September 2019 Homo sapiens:Glycolysis and gluconeogenesis - for workshop (ChEBI identifier normalization)
- 14:25, 17 September 2019 Homo sapiens:Non-genomic actions of 1,25-dihydroxyvitamin D3 (ChEBI identifier normalization)
- 14:25, 17 September 2019 Homo sapiens:Ferroptosis (ChEBI identifier normalization)
- 14:25, 17 September 2019 Homo sapiens:Oxidation by cytochrome P450 (ChEBI identifier normalization)
- 14:25, 17 September 2019 Homo sapiens:Acute viral myocarditis (ChEBI identifier normalization)
- 14:25, 17 September 2019 Homo sapiens:Flavan-3-ol metabolic pathway (ChEBI identifier normalization)
- 14:25, 17 September 2019 Homo sapiens:Krebs cycle disorders (ChEBI identifier normalization)
- 14:24, 17 September 2019 Homo sapiens:Pyrimidine metabolism and related diseases (ChEBI identifier normalization)
- 14:24, 17 September 2019 Homo sapiens:Purine metabolism and related disorders (ChEBI identifier normalization)
- 14:24, 17 September 2019 Homo sapiens:Phosphodiesterases in neuronal function (ChEBI identifier normalization)
- 14:24, 17 September 2019 Homo sapiens:White fat cell differentiation (ChEBI identifier normalization) (top)
- 14:24, 17 September 2019 Homo sapiens:Nucleotide metabolism (ChEBI identifier normalization)
- 14:24, 17 September 2019 Homo sapiens:NO/cGMP/PKG mediated neuroprotection (ChEBI identifier normalization)
- 14:24, 17 September 2019 Homo sapiens:Ethanol effects on histone modifications (ChEBI identifier normalization)
- 14:24, 17 September 2019 Homo sapiens:GPR40 role in insulin secretion (ChEBI identifier normalization)
- 14:23, 17 September 2019 Homo sapiens:Leptin-insulin signaling overlap (ChEBI identifier normalization)
- 14:23, 17 September 2019 Homo sapiens:Leptin and adiponectin (ChEBI identifier normalization)
- 14:23, 17 September 2019 Homo sapiens:Kennedy pathway from sphingolipids (ChEBI identifier normalization)
- 14:23, 17 September 2019 Homo sapiens:Amino acid metabolism (ChEBI identifier normalization)
- 14:23, 17 September 2019 Homo sapiens:MAPK signaling (ChEBI identifier normalization)
- 14:23, 17 September 2019 Homo sapiens:Epigallocatechin-3-O-gallate / epigallocatechin / epicatechin breakdown pathway (ChEBI identifier normalization)
- 14:23, 17 September 2019 Homo sapiens:Mitochondrial long chain fatty acid beta-oxidation (ChEBI identifier normalization)
- 14:23, 17 September 2019 Homo sapiens:Regulation of Wnt / B-catenin signaling by small molecule compounds (ChEBI identifier normalization)
- 14:22, 17 September 2019 Homo sapiens:MECP2 and associated Rett syndrome (ChEBI identifier normalization)
- 14:22, 17 September 2019 Homo sapiens:Methionine de novo and salvage pathway (ChEBI identifier normalization)
- 14:22, 17 September 2019 Homo sapiens:Melatonin metabolism and effects (ChEBI identifier normalization)
- 14:22, 17 September 2019 Homo sapiens:Overview of nanoparticle effects (ChEBI identifier normalization)
- 14:22, 17 September 2019 Homo sapiens:Triacylglyceride synthesis (ChEBI identifier normalization)
- 14:22, 17 September 2019 Homo sapiens:Nuclear receptors in lipid metabolism and toxicity (ChEBI identifier normalization)
- 14:22, 17 September 2019 Homo sapiens:Oxytocin signaling (ChEBI identifier normalization)
- 14:21, 17 September 2019 Homo sapiens:Complement system (ChEBI identifier normalization)
- 14:21, 17 September 2019 Homo sapiens:Blood clotting cascade (ChEBI identifier normalization)
- 14:21, 17 September 2019 Homo sapiens:Aryl hydrocarbon receptor pathway (ChEBI identifier normalization)
- 14:21, 17 September 2019 Homo sapiens:WikiPathways Test: Metabolites and Metabolic Interactions (ChEBI identifier normalization)
- 14:21, 17 September 2019 Homo sapiens:Glycerophospholipid biosynthetic pathway (ChEBI identifier normalization)
- 14:21, 17 September 2019 Homo sapiens:PDGF pathway (ChEBI identifier normalization)
- 14:21, 17 September 2019 Homo sapiens:Nanomaterial induced apoptosis (ChEBI identifier normalization)
- 14:21, 17 September 2019 Homo sapiens:TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) (ChEBI identifier normalization)
- 14:21, 17 September 2019 Homo sapiens:Dopamine metabolism (ChEBI identifier normalization)
- 14:20, 17 September 2019 Homo sapiens:One-carbon metabolism (ChEBI identifier normalization)
- 14:20, 17 September 2019 Homo sapiens:Parkinson's disease pathway (ChEBI identifier normalization)
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)